On December 23, 2020, Jeffrey B. Kindler resigned from the Board of Directors of vTv Therapeutics Inc. (the “Company”), effective as of December 23, 2020. On December 30, 2020, the Board of Directors (the “Board”) of vTv Therapeutics Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Robin E. Abrams, as Executive Chairman and a member of the Board, effective immediately. Ms. Abrams will serve a term through the date of the next annual meeting of the Company’s stockholders. In addition, Ms. Abrams will serve as a member of the Nominating and Corporate Governance Committee. In connection with her appointment, Ms. Abrams resigned from her role as Executive Vice President and General Counsel of the Company, a position which she has held since 2016. Ms. Abrams is General Counsel and Chief Administrative Officer of SIGA Technologies Inc. a position she has held since April 2016. Prior to her roles at SIGA and the Company, Ms. Abrams had an extensive career in the pharmaceutical industry and served as an Assistant United States Attorney in the Southern District of New York. David M. Lambert III (“Trey”) has been promoted to Senior Vice President and General Counsel in connection with Ms. Abrams’ appointment as Executive Chairman and resignation as Executive Vice President and General Counsel. Mr. Lambert was previously Vice President, Senior Counsel for the Company, a role he has held since 2016. Prior to his role at the Company, Mr. Lambert was an associate at Latham & Watkins LLP in its Washington, D.C. office and at Womble Bond Dickinson in its Winston-Salem, NC office.